Listing 1 - 10 of 12 | << page >> |
Sort by
|
Choose an application
precision medicine --- oncology --- clinical medicine --- personalised medicine --- individualised therapy --- Personalized medicine --- Cancer --- Oncology --- Oncology. --- Personalized medicine. --- Treatment --- Treatment. --- Individualized medicine --- Medical care --- Pharmacogenetics --- Tumors --- Cancers --- Carcinoma --- Malignancy (Cancer) --- Malignant tumors --- Therapy --- Precision medicine --- Precision medicine. --- Médecine de précision --- Cancérologie --- Traitement
Choose an application
“Personalised Nutrition” represents any initiative that attempts to provide tailor-made healthy eating advice based on the nutritional needs of each individual, as these are dictated by the individual’s behaviour, phenotype and/or genotype, and their interactions. This Special Issue of Nutrients is dedicated to the development, implementation and assessment of the effectiveness of evidence-based “Personalised Nutrition” strategies. In this regard, a selection of reviews and original research manuscripts will bring together the latest evidence on how lifestyle habits, physiology, nutraceuticals, gut microbiome and genetics can be integrated into nutritional solutions, specific to the needs of each individual, for maintaining health and preventing diseases.
n/a --- gene-based --- taste --- postprandial leptin --- children --- personalised --- obesity --- macronutrient composition --- gastrointestinal symptoms --- postprandial adiponectin --- formula diet --- avoidance diet --- weight loss --- weight --- omega-3 fatty acids --- microbiome --- genotype --- nutrition --- direct-to-consumer test --- intervention --- clinical nutrition --- postprandial total ghrelin --- dietary intervention --- microbiota --- low-carbohydrate diet --- insulin --- FADS polymorphism --- adults --- genetics --- diet --- healthcare professionals --- HbA1c --- PROX1 gene --- phenotype --- high-fat meal --- glucose --- personalised nutrition --- irritable bowel syndrome --- dietary recommendation --- postprandial metabolic fingerprinting --- type 2 diabetes mellitus risk --- high-carbohydrate meal --- health --- ultra-high performance liquid chromatography --- food allergy --- normo-carbohydrate meal --- nutrimetabolomics --- type 2 diabetes --- nutrigenetics --- gene–diet interaction --- personalized nutrition --- gene-diet interaction
Choose an application
food production --- food safety --- green processing --- personalised nutrition --- health promotion --- Food industry and trade --- Nutrition --- Food industry and trade. --- Nutrition. --- Alimentation --- Food --- Health --- Physiology --- Diet --- Dietetics --- Digestion --- Food habits --- Malnutrition --- Food preparation industry --- Food processing industry --- Food technology --- Food trade --- Agricultural processing industries --- Processed foods --- Health aspects --- Processing
Choose an application
Adverse drug reactions are one of the major constraints when using drugs. These adverse reactions can impact healthcare systems as strongly as many prevalent diseases. Identifying DNA variants associated with adverse drug reactions can help personalize medicine and sustain healthcare systems. This book delves into new advances in pharmacogenetics of cardiovascular, cancer, and nervous system drugs. It may be useful for clinicians and patients to understand the basics of pharmacogenetics.
5-fluorouracil --- capecitabine --- fluoropyrimidine --- thymidylate synthase --- thymidylate synthase enhancer region --- upstream stimulatory factor 1 --- adverse drug reactions --- pharmacogenomics --- epistasis --- random forest --- statin --- cardiovascular disease --- colorectal cancer --- personalised medicine --- toxicity --- (es)citalopram --- drug-gene-interaction --- drug-drug-interaction --- drug-drug-gene-interaction --- the PharmLines initiative --- antipsychotic agents --- pharmacogenetics --- cytochrome P-450 enzyme system --- psychotic disorders --- precision medicine --- direct oral anticoagulants --- clinical implementation --- atorvastatin --- SLCO1B1 --- HLA --- cutaneous adverse drug reaction --- SCAR --- genetic polymorphism --- antiepileptics --- CYP450 enzymes --- platelet reactivity --- single-nucleotide variants --- acute coronary syndrome --- clopidogrel --- genotype --- allele --- polymorphism --- HLA B --- CYP2C9*3 --- cutaneous adverse drug reactions (CADRs) --- anti-epileptic drugs (AEDS) --- phenytoin (PHT) --- genetic risk factors --- South India --- India --- cardiology --- adverse events --- guidelines --- n/a
Choose an application
Blindness and visual impairment impact significantly on an individual’s physical and mental well-being. Loss of vision is a global health problem, with approximately 250 million of the world’s population currently living with vision loss, of which 36 million are classified as blind. Visual impairment is more frequent in the elderly, with cataract and age-related macular degeneration (AMD) accounting for over 50% of cases globally. Oxidative stress has been strongly implicated in the pathogenesis of both conditions, and consequently the role of nutritional factors, in particular carotenoids and micronutrient antioxidants, have been investigated as possible preventative or therapeutic strategies. Dry eye syndrome (DES) is one of the most common ophthalmic conditions in the world. DES occurs where the eye does not produce enough tears and/or the tears evaporate too quicklyleading to discomfort and varying degrees of visual disturbance. There has recently been a great deal of interest in the potential for oral or topical supplementation with essential fatty acids (EFAs), specifically omega-3 and omega-6 fatty acids, as an adjunct to conventional treatments for DES. The objective of this Special Issue on ‘Nutrition and Eye Health’ is to publish papers describing the role of nutrition in maintaining eye health and the use of nutritional interventions to prevent or treat ocular disease. A particular (but not exclusive) emphasis will be on papers (reviews and/or clinical or experimental studies) relating to cataract, AMD and DES.
polyphenols --- n/a --- crocin --- chyrsin --- glaucoma --- dietary assessment --- photoreceptor degeneration --- dry eye --- RR-zeaxanthin --- nutritional supplements --- drug discovery --- corneal neovascularization (CNV) --- AMD --- dietary antioxidants --- micronutrients --- age-related macular degeneration --- preclinical models --- lenses --- microvascular lesions --- cyclooxigenase-2 (COX-2) --- angiogenesis --- fish oil --- macrophage --- anti-oxidant --- vascular endothelial growth factor (VEGF) --- rosmarinic acid --- visual cycle --- diabetic retinopathy --- lutein --- gut-retina axis --- light damage --- crocetin --- supplements --- clinical practice guidelines --- nutrition --- light --- eye disease --- dietary habits --- flavonoids --- phytoconstituents --- saffron --- carotenoids --- fatty acid --- electroretinography --- lens --- advanced glycation end products --- interleukin-1? (IL-1?) --- mesozeaxanthin (RS zeaxanthin) --- endoplasmic reticulum stress --- omega-3 polyunsaturated fatty acids --- clinical survey --- corneal chemical burn --- reduced glutathione --- omega-3 --- AGREE II --- retina --- inflammation --- anti-inflammatory --- retinal pigment epithelium --- diet --- Lactobacillus paracasei KW3110 --- Crocus Sativus L. --- saponins --- cataract --- CODS --- neoangiogenesis --- estrogen-deficient rats --- food frequency questionnaire --- gut microbiota --- antioxidant supplements --- sinapic acid --- personalised medicine --- systematic reviews --- nuclear factor-kappaB (NF-?B) --- diabetes --- Cucurbita argyrosperma --- oxidative stress --- endoplasmic reticulum
Choose an application
This book contains research articles on the advances in the aetiology of idiopathic scoliosis (IS), the spinal growth related to the implementation of growth modulation for the surgical treatment of early-onset IS, the non-surgical treatment of IS using Physiotheraputic Scoliosis Specific Exercises, and braces. Additionally, it focuses on issues related to surgical treatment, issues related to body posture and the quality of life of this sensitive group of people. The high quality of published papers in this Special Issue of the JCM serve these objectives.
Medicine --- idiopathic scoliosis --- health-related quality of life --- cultural adaptation --- Italian Spine Youth Quality of Life Questionnaire --- systematic review --- meta-analysis --- adolescent idiopathic scoliosis --- brace therapy --- brace concepts --- rigid brace --- night time brace --- ring apophysis --- maturation --- ossification --- fusion --- scoliosis --- nighttime orthotic treatment --- surgery --- quality of life --- paraspinal muscles --- cross-sectional area --- posterior approach --- computed tomography --- Italian spine youth quality of life questionnaire --- SRS-22 --- 22q11.2 deletion syndrome --- human model --- neuromuscular scoliosis --- radiography --- MRI --- curve morphology --- intraspinal anomaly --- body height --- pulmonary function test --- Cobb angle --- iTRAQ --- α-actin --- progressive --- differentially expressed proteins --- bracing --- physiotherapeutic scoliosis-specific exercise --- physical activity --- adherence --- spinal appearance --- shared decision-making --- personalised approach --- sclerostin --- osteocytes --- β-catenin --- Wnt signaling pathway --- scoliometer --- truncal asymmetry --- lateral spinal profile --- surface topography --- aetiology --- spinal deformities --- pathobiomechanics --- follow-up study --- Rett syndrome --- motor skills --- telerehabilitation --- physical therapy modalities --- home exercise program --- neurodynamic functions --- assessment --- pain --- treatment --- early onset scoliosis --- non-operative treatment --- body posture --- sports activity --- corrective exercises --- digital photography --- n/a
Choose an application
Alternative treatment modes for antibiotic-resistant bacterial pathogens have become a public health priority. Bacteriophages are bacterial viruses that infect and lyse bacterial cells. Since bacteriophages are frequently bacterial host species-specific and can often also infect antibiotic-resistant bacterial cells, they could represent ideal antimicrobials for fighting the antibiotic resistance crisis. The medical use of bacteriophages has become known as phage therapy. It is widely used in Russia, where phage cocktails are sold in pharmacies as an over-the-counter drug. However, no phage product has been registered for medical purposes outside of the former Soviet Union. The current Special Issue of Viruses contains a collection of papers from opinion leaders in the field who explore hurdles to the introduction of phage therapy in western countries. The articles cover diverse topics ranging from patent to regulatory issues, the targeting of suitable bacterial infections, and the selection and characterization of safe and efficient phage cocktails. Phage resistance is discussed, and gaps in our knowledge of phage–bacterium interactions in the mammalian body are revealed, while other articles explore the use of phages in food production and processing.
alginate --- abortive infection --- n/a --- bacterial resistance --- bacteriophages --- ATMP --- MALDI-MS --- adaptation --- Bacteriophage --- horizontal gene transfer --- adaptive immunity --- co-evolution --- Listeria ivanovii --- personalised medicines --- pH stability --- phage-human host interaction --- vB_SauM-fRuSau02 --- antimicrobial resistance --- phagodisinfection --- biofilm --- capsule depolymerase --- animal model --- phage cocktails --- Enterococcus --- cases report --- zoonosis --- resistance --- magistral formula --- experimental therapy --- Belgium --- phage therapy --- E. faecalis --- nontraditional antibacterial --- industrial phage application --- Democratic Republic of the Congo --- OrthoMCL --- Germany --- high-throughput sequencing --- antimicrobial --- infection --- antibiotic therapy --- Kayvirus --- phages --- Twortlikevirus --- bacterial disease --- human host --- Pseudomonas aeruginosa --- phage --- multidrug-resistant bacteria --- bacterial infection --- Salmonella Typhi --- rhamnopolysaccharide --- compassionate use --- crop production --- compounding pharmacy --- antimicrobial resistance (AMR) --- best practices --- bacteriophage efficacy --- phage sensitivity --- antibiotic-resistance --- antibiotic --- lysins --- PTMP --- Escherichia coli --- typhoid fever --- patent landscape --- phage preparation --- innate immunity --- anti-phage antibodies --- immunology --- Staphylococcus aureus --- global health --- clinical trial --- adsorption --- Brussels --- phage-resistance --- Galleria mellonella --- science communication --- history of science --- virus–host interactions --- foodborne illness --- prophage --- resistance management --- biofilms --- IND --- immunomodulation --- frequency of resistance --- capsule --- gastrointestinal tract --- phage-host interactions --- disinfection --- production --- bacteriophage therapy --- bacteriophage --- Staphylococcus --- magistral preparation --- extended-spectrum beta lactamases (ESBL) --- Viral proteins --- antibiotic resistance --- genomics --- phage biocontrol --- therapy --- target selection --- viral genomes --- evolution --- pharmaceutical paradigm shift --- personalized medicine --- pharmaceutical legislation --- food safety --- regulation --- virulence --- developing countries --- infectious disease --- regulatory framework --- sustainable agriculture --- Klebsiella pneumoniae --- virus-host interactions
Choose an application
This open access book reflects on matters of social and ethical concern raised in the daily practices of those working in and around precision oncology. Each chapter addresses the experiences, concerns and issues at stake for people who work in settings where precision oncology is practiced, enacted, imagined or discussed. It subsequently discusses and analyses bioethical dilemmas, scientific challenges and economic trade-offs, the need for new policies, further technological innovation, social work, as well as phenomenological research. This volume takes a broad actor-centred perspective as, whenever cancer is present, the range of actors with issues at stake appears almost unlimited. This perspective and approach opens up the possibility for further in-depth and diverse questions, posed by the actors themselves, such as: How are cancer researchers navigating biological uncertainties? How do clinicians and policy-makers address ethical dilemmas around prioritisation of care? What are the patients’ experiences with, and hopes for, precision oncology? How do policy-makers and entrepreneurs envisage precision oncology? These questions are of great interest to a broad audience, including cancer researchers, oncologists, policy-makers, medical ethicists and philosophers, social scientists, patients and health economists.
Precision Medicine. --- Biomarkers, Tumor. --- Biochemical Tumor Markers --- Biological Tumor Marker --- Biological Tumor Markers --- Biomarkers, Cancer --- Marker, Biochemical Tumor --- Marker, Biologic Tumor --- Marker, Biological Tumor --- Marker, Neoplasm Metabolite --- Marker, Tumor Metabolite --- Markers, Biochemical Tumor --- Markers, Biological Tumor --- Markers, Neoplasm Metabolite --- Markers, Tumor Metabolite --- Metabolite Markers, Tumor --- Neoplasm Metabolite Markers --- Tumor Markers, Biologic --- Tumor Metabolite Marker --- Biochemical Tumor Marker --- Cancer Biomarker --- Carcinogen Markers --- Markers, Tumor --- Metabolite Markers, Neoplasm --- Tumor Biomarker --- Tumor Marker --- Tumor Markers, Biochemical --- Tumor Markers, Biological --- Biologic Tumor Marker --- Biologic Tumor Markers --- Biomarker, Cancer --- Biomarker, Tumor --- Cancer Biomarkers --- Marker, Tumor --- Markers, Biologic Tumor --- Markers, Carcinogen --- Metabolite Marker, Neoplasm --- Metabolite Marker, Tumor --- Neoplasm Metabolite Marker --- Tumor Biomarkers --- Tumor Marker, Biochemical --- Tumor Marker, Biologic --- Tumor Marker, Biological --- Tumor Markers --- Tumor Metabolite Markers --- Neoplasm Proteins --- P Health --- P-Health --- Personalized Medicine --- Theranostics --- Individualized Medicine --- Predictive Medicine --- Medicine, Individualized --- Medicine, Personalized --- Medicine, Precision --- Medicine, Predictive --- Theranostic --- Pharmacogenomic Variants --- Pharmacogenetics --- Patient-Specific Modeling --- cancer biomarkers --- Sociology of medicine --- Science and Technology Studies --- Oncology --- Philosophy of medicine --- precision oncology --- personalised cancer treatments --- health technology assessment --- Open access
Choose an application
Irving Langmuir coined the name “plasma” to describe an ionized gas back in 1927. Just over 90 years later, plasma technology is becoming increasingly important in our daily life. For example, in the medical field and dentistry, plasma is used as a method of disinfection and sterilization. Moreover, additional potential novel applications of this technology in different forms of therapy have been proposed. In the agricultural sector, plasma technology could contribute to higher crop yields by enhancing seed germination and the growth of plants, as well as the preservation of foods by disinfection. Plasma technology could also be utilized in environmental applications, including water treatment and remediation, as well as treatment of exhaust gases. Although recent extensive studies have uncovered the broad potential of plasma technology, its mechanisms of action remain unclear. Therefore, further studies aimed at elucidating the molecular mechanisms of plasma technology are required. This book is composed of original articles and reviews investigating the molecular mechanisms of plasma biology. Relevant areas of study include applications in plasma medicine, plasma agriculture, as well as plasma chemistry. Studies on potential therapeutic approaches using plasma itself and plasma-treated solutions are also included.
cold jet atmospheric pressure plasma --- reactive oxygen and nitrogen species --- backbone cleavage --- hydroxylation --- carbonyl formation --- cold atmospheric plasma --- autophagy --- silymarin nanoemulsion --- PI3K/mTOR pathway --- wound healing --- oncology --- regenerative medicine --- plasma --- atmospheric pressure plasma jets --- large-scale imaging --- machine learning --- cancer treatment --- cellular imaging --- reactive oxygen species --- mesoporous silica nanoparticles --- biomaterials --- bone regeneration --- cytotoxicity --- proliferation --- osteogenic differentiation --- plasma-activated medium --- TRAIL --- DR5 --- apoptosis --- ROS/RNS --- atmospheric-pressure plasma --- titanium --- amine --- mesenchymal stem cells --- antibiotic resistant bacteria --- antibiotic resistance gene --- disinfection --- E. coli --- inactivation --- sterilization --- cell migration --- endothelial cells VEGF --- gynaecological oncology --- vulva cancer --- risk factors --- plasma tissue interaction --- premalignant lesions --- cancer development --- patient stratification --- individualised profiling --- predictive preventive personalised medicine (PPPM/3PM) --- treatment --- Candida albicans --- cold plasma treatment --- genome --- hydrolytic enzyme activity --- carbon assimilation --- drug susceptibility --- malignant melanoma --- acidification --- nitrite --- acidified nitrite --- nitration --- membrane damage --- CAP --- cancer --- cold atmospheric pressure plasma --- hydrogen peroxide --- hypochlorous acid --- moDCs --- peroxynitrite --- RNS --- ROS --- non-thermal plasma --- biological activity --- breast cancer --- solution plasma process --- aqueous solutions --- chitin --- chitosan --- degradation --- deacetylation --- non-thermal atmospheric pressure plasma --- Pectobacteriaceae --- Dickeya spp. --- Pectobacterium spp. --- antibacterial --- plant protection --- agriculture --- selective cancer treatment --- reaction network --- mathematical modeling --- n/a --- Mdm2–p53 --- plasma treatment --- molecular dynamic (MD) simulations --- Mdm2-p53
Choose an application
Most of the treatments in medicine are patient specific, aren’t they? So why should we bother with individualizing implants if we adapt our therapy to patients anyway? Looking at the neighboring field of oncologic treatment, you would not question the fact that individualization of tumor therapy with personalized antibodies has led to the thriving of this field in terms of success in patient survival and positive responses to alternatives for conventional treatments. Regarding the latest cutting-edge developments in orthopedic surgery and biotechnology, including new imaging techniques and 3D-printing of bone substitutes as well as implants, we do have an armamentarium available to stimulate the race for innovation in medicine. This Special Issue of Journal of Personalized Medicine will gather all relevant new and developed techniques already in clinical practice. Examples include the developments in revision arthroplasty and tumor (pelvic replacement) surgery to recreate individual defects, individualized implants for primary arthroplasty to establish physiological joint kinematics, and personalized implants in fracture treatment, to name but a few.
patient specific implant --- custom made implant --- revision hip --- Paprosky --- pelvic discontinuity --- highly cancellous --- implant surface --- tibia --- titanium alloy --- 3D printing --- megaendoprosthesis --- orthopedic oncology --- limb salvage --- patient safety management --- vascular bypass --- soft tissue sarcoma --- vascular reconstruction --- shoulder arthroplasty --- X-ray images --- implant classification --- deep learning --- dense residual ensemble-network --- rotational invariant augmentation --- Three-Dimensional Printing (3DP) --- custom implant --- patient-specific implants (PSI) --- spinal surgery --- total knee replacement --- total knee arthroplasty --- kinematic alignment --- slope --- rotation --- navigation-assisted surgery --- tumor orthopedics --- oncologic orthopedics --- patient specific --- tumor surgery --- bone defects --- hip detection --- deep convolutional neural network --- radiography --- leg alignment --- patient-specific instruments --- custom-made implant --- rotational correction --- custom-made --- rTKA --- 3D-printed --- individual --- limb-salvage --- cone --- customised --- personalised --- knee replacement --- native knee morphology --- femoral J-Curve --- principal component analysis --- geometric parameter analysis --- individualized alignment --- restricted kinematic alignment --- robotic-assisted TKA --- MAKO --- safe zone --- pelvic tumors --- 3D printed prostheses --- computer aided design pelvic reconstruction --- arthroplasty --- complications --- bone tumor --- pelvis --- patient-specific --- individualized --- 3D-printing --- unicondylar knee arthroplasty --- unicompartmental knee replacement --- unicondylar knee replacement --- partial knee arthroplasty --- partial knee replacement --- UKA --- UKR --- augmented reality --- image-guided surgery --- intraoperative imaging --- simulation --- mixed reality --- reversed shoulder arthroplasty --- 3D planning --- total hip arthroplasty --- finite element method --- cemented and uncemented acetabular fixation --- polyethylene wear patterns --- cervical–diaphyseal angle --- center of rotation --- material head --- size head --- liner thickness --- preoperative planning --- patient-specific THA --- target zone --- leg length discrepancy --- range of motion --- edge loading --- TKA --- tricompartmental knee osteoarthritis --- iTotal --- n/a --- cervical-diaphyseal angle
Listing 1 - 10 of 12 | << page >> |
Sort by
|